Evidence map›Paper›PMID 36509292›Full record

ArticleJCI insight2022

Single-cell analysis of senescent epithelia reveals targetable mechanisms promoting fibrosis.

Eoin D O'Sullivan, Katie J Mylonas, Rachel Bell, Cyril Carvalho, David P Baird, Carolynn Cairns, Kevin M Gallagher, Ross Campbell, Marie Docherty, Alexander Laird and 10 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. T-Cell Remodeling in Renal Fibrosis: From Acute Injury to Chronic Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. LAPTM5: A Novel Target in an Old Fight against Tubular Senescence.Journal of the American Society of Nephrology : JASN · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 4 countries.

Eoin D O'SullivanCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Katie J MylonasCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Rachel BellCentre for Cardiovascular Science, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Cyril CarvalhoCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
David P BairdCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Carolynn CairnsCentre for Cardiovascular Science, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Kevin M GallagherDepartment of Urology, Western General Hospital, Edinburgh, United Kingdom.
Ross CampbellCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Marie DochertyCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Alexander LairdDepartment of Urology, Western General Hospital, Edinburgh, United Kingdom.
Neil C HendersonCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Tamir ChandraMRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Kristina KirschnerThe Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
Bryan ConwayCentre for Cardiovascular Science, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Gry H DihaziInstitute for Clinical Chemistry/UMG-Laboratories.
Michael ZeisbergClinic for Nephrology and Rheumatology, and.
Jeremy HughesCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Laura DenbyKidney Health Service, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Hassan DihaziClinic for Nephrology and Rheumatology, and.
David A FerenbachCentre for Inflammation Research, Queen's Medical Research Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Centre for Inflammation Research · GBThe Queen's Medical Research Institute · GBRoyal Brisbane and Women's Hospital · AUWestern General Hospital · GBCancer Research UK Scotland Institute · GBCenter for Rheumatology · USClinical Science Institute · USInstitute of Genetics and Cancer · GBUniversitätsmedizin Göttingen · DE

Funding

Medical Research Council MR/N002210/1Medical Research Council MR/W00089X/1Wellcome TrustWellcome Trust 100171/Z/12/Z
6 · The paper itself

Abstract

Progressive fibrosis and maladaptive organ repair result in significant morbidity and millions of premature deaths annually. Senescent cells accumulate with aging and after injury and are implicated in organ fibrosis, but the mechanisms by which senescence influences repair are poorly understood. Using 2 murine models of injury and repair, we show that obstructive injury generated senescent epithelia, which persisted after resolution of the original injury, promoted ongoing fibrosis, and impeded adaptive repair. Depletion of senescent cells with ABT-263 reduced fibrosis in reversed ureteric obstruction and after renal ischemia/reperfusion injury. We validated these findings in humans, showing that senescence and fibrosis persisted after relieved renal obstruction. We next characterized senescent epithelia in murine renal injury using single-cell RNA-Seq. We extended our classification to human kidney and liver disease and identified conserved profibrotic proteins, which we validated in vitro and in human disease. We demonstrated that increased levels of protein disulfide isomerase family A member 3 (PDIA3) augmented TGF-β-mediated fibroblast activation. Inhibition of PDIA3 in vivo significantly reduced kidney fibrosis during ongoing renal injury and as such represented a new potential therapeutic pathway. Analysis of the signaling pathways of senescent epithelia connected senescence to organ fibrosis, permitting rational design of antifibrotic therapies.

Indexed as

Cellular SenescenceKidneyAnimalsEpitheliumFibrosisHumansMiceSingle-Cell AnalysisBioinformaticsCell BiologyCellular senescenceFibrosisNephrology

Identifiers

PMID36509292
PMCPMC9746814
OpenAlexW4309497294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.